 (BrJ Ophthalmol 1993; 77: 646-649) 
Recently epiretinal membranes were reported in seven ofnine patients with NF 2. An association was also suggested between optic disc glioma and NF 2. This observation was based on early published reports without providing a new case. " In this current study we examined patients with NF 2 to further define the ocular phenotype of this disease.
Patients and methods Between September 1991 and June 1992 we prospectively examined six consecutive patients with NF 2. Nobody was excluded from the study. All patients were admitted to the neurosurgery department, except for patient 5 who had the eye examination while visiting her father (patient 4). The diagnosis was confirmed by neurosurgical biopsy in four patients and by neuroimaging in two. Patients 4 and 5 were father and daughter, the remaining four were unrelated. The eye examination included determination of visual acuity, biomicroscopy before and after pupillary dilatation with special attention to the presence of iris hamartomas and lens opacities, and dilated fundus examination. Patients 2, 3, and 6 had fluorescein angiography. The severity ofepiretinal membranes was graded according to Gass'2 into grade 0 ('cellophane' maculopathy), grade 1 ('crinkled cellophane' maculopathy), and grade 2 ('macular pucker').
Results
The findings are summarised in Table 1 There is blockage offluorescence corresponding to the superotemporal lesion which in later stages showed increasing leakage.
towards the centre of the macula, and there was no leakage. CASE 3 A 30-year-old man underwent emergency surgery for a giant right acoustic neuroma with signs of increased intracranial pressure. Six years earlier, a left acoustic neuroma had been removed. MRI revealed additional tumours on other cranial nerves, in the left temporal lobe, the medulla, and the spinal cord.
Best corrected visual acuity was 20/25 in the right eye and 20/30 in the left eye. There was mild bilateral facial paresis. Bilateral cataracts were present. The opacity was central subcapsular in the right eye and peripheral cortical in the left eye. There was bilateral papilloedema. In the right eye a subtle greyish epiretinal membrane was seen superiorly to the fovea and a 'crinkled cellophane' appearance was noted between the temporal arcades. The left fundus showed a semitranslucent epiretinal membrane over the entire macula with a Swiss cheese-like hole temporal to the fovea. In addition, a round white lesion was located temporosuperiorly (Fig  2) . On a fundus photograph of left eye taken 2 years previously, no papilloedema and no folds between disc and macula were found, but the epiretinal membrane and the white lesion appeared identical. On fluorescein angiography of the left eye the abnormal vascular pattern in the macula was clearly seen (Fig 3) . The white lesion showed early blockage and late leakage of dye. We believe that the lesion represents an astrocytic hamartoma. CASE 6 A 37-year-old woman was referred for evaluation of progressive ataxia and hearing loss. She had had surgery for a right acoustic neuroma 7 years previously and a right glossopharyngeal neuroma 1 year later. There was neuroradiological evidence of recurrent acoustic neuroma on the right,' an acoustic neuroma on the left, bilateral trigeminal neuromas, a spinal neuroma at the Cl level, and an arachnoid cyst in the left temporal lobe. There was a right abducens and Landau, Yajargil Figure 4 Fundus photograph ofthe right eye ofpatient 6 shows a large smooth white gliotic tumour overlying the disc. bilateral facial palsy. A partial right tarsorrhaphy had been performed previously. The patient gave a history of poor vision in her right eye since childhood.
Best corrected visual acuity was hand movements in the right eye and 20/100 in the left eye. The right cornea had a superficial peripheral scar but was clear centrally. Both lenses had posterior cortical opacities which were paracentral in the right eye and peripheral in the left eye. In the right eye funduscopy revealed a large white tumour covering the disc (Fig 4) 14 Kaye et al recently reported epiretinal membranes in seven of nine patients with NF 2. 0 One patient's eye was studied histologically, and intraretinal glial proliferation with an overlying epiretinal membrane was found, consisting of astrocytic cells with positive staining for glial fibrillary acid protein. The authors propose that this may represent an early glial hamartoma, but they point out that this patient's clinical appearance of the epiretinal membrane was the most severe and that it may not be representative for epiretinal membranes in NF 2. In our study, three of the six eyes with epiretinal membranes were similar in severity, showing a definite grey or white membrane which obscured the underlying retinal vessels and caused marked retinal distortion. None of these three patients had fluorescein leakage, similar to the one patient who had fluorescein angiography in Kaye et al's series. We also looked for associated disturbance at the level of the retinal pigment epithelium (RPE), but did not find definite RPE abnormalities in the involved eyes. We thus cannot conclude whether epiretinal membranes found in patients with NF 2 are an abortive form of CPERHs or whether they represent an isolated entity.
Idiopathic epiretinal membranes occur predominantly in patients older than 50 years and their incidence rises with increasing age. 2 Young patients without posterior vitreous detachment rarely develop epiretinal membranes, but such membranes of presumably congenital origin in children and young adults have been described.'25 16 Formation of epiretinal membranes occurs in a variety of ocular conditions such as retinal vascular diseases, retinal tears, rhegmatogenous retinal detachment, vitreous inflammatory diseases, ocular trauma, intraocular tumours, and tapetoretinal degenerations. In the present study the six eyes with epiretinal membranes had no ocular conditions implicated in epiretinal membrane formation.
The histopathology of epiretinal membranes has been extensively studied.17-21 Definite identification of the cells of origin is difficult owing to the ability of retinal glial and RPE cells to change into cells with a similar appearance and function.'2 NF 2 is a disease in which extensive proliferation of glial cells in the central nervous system occurs and it is thus not surprising if a similar process occurs in the retina which constitutes a part of the central nervous system. It is remarkable that patients 4 and 5 did not show any specific ocular signs of NF 2. They both represent the only familial cases in this study as opposed to the remaining four cases which are sporadic. The mother of patient 4 was deafand died ofa brain tumour. Patient 4 did not have a neurosurgical procedure until the age of 62. His 33-year-old daughter, patient 5, was diagnosed only because of the positive family history and is almost asymptomatic. Another 38-year-old daughter is known to harbour bilateral acoustic neuromas; she refused an eye examination. The disease in this family seems to run a milder course and not to show ocular manifestations when compared with the new mutation cases.
We believe that the disc tumour in the right eye of patient 6 and the photograph of a tumour found in the slide collection both represent examples of optic disc gliomas. It has been suggested that these extremely rare tumours may be found specifically in patients with NF 2.1 This assumption was based on reports published long before the identification of NF 2 as a distinct disease.22-24 The three reported patients were all deafand had additional features which retrospectively put them into the diagnostic category of NF 2.
We conclude that epiretinal membranes represent a frequent sign in NF 2, thus confirming the report by Kaye et al.'0 These membranes are possibly of congenital origin similar to those previously reported in healthy children and young adults. In a larger study the frequency and specificity of epiretinal membranes as a sign of NF 2 should be evaluated.
We further provide two new cases of optic disc gliomas in patients with a confirmed diagnosis of NF 2. These rare tumours are specific for the disease and should thus be added to the list of ocular manifestations of NF 2.
This study was presented at the 9th International NeuroOphthalmology Symposium in Williamsburg, Virginia, 28 June- 3 July 1992.
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